General Information of Drug Transporter (DT)
DT ID DTD0360 Transporter Info
Gene Name SLC43A1
Transporter Name L-type amino acid transporter 3
Gene ID
8501
UniProt ID
O75387
Post-Translational Modification of This DT
Overview of SLC43A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

57

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A1 Asparagine 57 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

212

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A1 Asparagine 212 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

229

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC43A1 Asparagine 229 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        13 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

165

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 165 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

174

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 174 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

177

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 177 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

178

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 178 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC43A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

237

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 237 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC43A1 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

262

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 262 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC43A1 [3] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

267

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 267 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC43A1 [3] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

272

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 272 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC43A1 [5] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

277

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 277 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC43A1 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

285

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 285 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

298

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 298 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

301

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 301 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

307

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Serine 307 has the potential to affect its expression or activity.

  Threonine

        12 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A1 [8] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

166

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 166 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

181

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 181 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC43A1 [5] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

246

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 246 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC43A1 [5] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

252

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 252 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC43A1 [5] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

255

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 255 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC43A1 [5] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 256 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC43A1 [8] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

284

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 284 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

310

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 310 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

314

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 314 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC43A1 [9] , [15]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

558

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Threonine 558 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A1 [8] , [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Tyrosine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC43A1 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

175

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Tyrosine 175 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC43A1 [5] , [16]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

251

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC43A1 Tyrosine 251 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC43A1 [17]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

264

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC43A1 Lysine 264 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: LAT3_HUMAN)
2 Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis. J Proteome Res. 2015 Dec 4;14(12):5341-7.
3 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
4 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
5 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
6 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
7 Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants. Elife. 2016 Sep 30;5:e18296.
8 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
9 Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
10 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
11 Targeted analysis of tyrosine phosphorylation by immuno-affinity enrichment of tyrosine phosphorylated peptides prior to mass spectrometric analysis. Methods. 2012 Feb;56(2):268-74.
12 Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
13 Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
14 Phosphoproteome Characterization of Human Colorectal Cancer SW620 Cell-Derived Exosomes and New Phosphosite Discovery for C-HPP. J Proteome Res. 2016 Nov 4;15(11):4060-4072.
15 Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
16 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
17 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.